400 related articles for article (PubMed ID: 12695913)
21. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract.
Chang JG; Chen YJ; Perng LI; Wang NM; Kao MC; Yang TY; Chang CP; Tsai CH
Eur J Cancer; 1999 Apr; 35(4):647-51. PubMed ID: 10492641
[TBL] [Abstract][Full Text] [Related]
23. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
[TBL] [Abstract][Full Text] [Related]
24. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
[TBL] [Abstract][Full Text] [Related]
25. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Tsao H; Zhang X; Benoit E; Haluska FG
Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
[TBL] [Abstract][Full Text] [Related]
26. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
[TBL] [Abstract][Full Text] [Related]
27. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.
Ueda K; Nishijima M; Inui H; Watatani M; Yayoi E; Okamura J; Yasutomi M; Nakamura Y; Miyoshi Y
Jpn J Cancer Res; 1998 Jan; 89(1):17-21. PubMed ID: 9510470
[TBL] [Abstract][Full Text] [Related]
28. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
Dong JT; Li CL; Sipe TW; Frierson HF
Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884
[TBL] [Abstract][Full Text] [Related]
29. PTEN/MMAC1 mutations in hepatocellular carcinomas.
Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the PTEN/MMAC1 tumour suppressor gene in primary human malignant mesotheliomas.
Papp T; Schipper H; Pemsel H; Unverricht M; Muller KM; Wiethege T; Schiffmann D; Rahman Q
Oncol Rep; 2001; 8(6):1375-9. PubMed ID: 11605070
[TBL] [Abstract][Full Text] [Related]
31. [Detection of mutation in exon 5 and exon 8 of PTEN in laryngeal squamous cell carcinoma].
Bai WL; Gao H; Ren Z; Pan ZM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):13-6. PubMed ID: 15127561
[TBL] [Abstract][Full Text] [Related]
32. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
Liu J; Babaian DC; Liebert M; Steck PA; Kagan J
Mol Carcinog; 2000 Nov; 29(3):143-50. PubMed ID: 11108659
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
35. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
36. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W
Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway.
Wen YG; Wang Q; Zhou CZ; Qiu GQ; Peng ZH; Tang HM
Oncol Rep; 2010 Jul; 24(1):89-95. PubMed ID: 20514448
[TBL] [Abstract][Full Text] [Related]
38. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
39. PTEN/MMAC1 expression in melanoma resection specimens.
Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H
Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
Li YL; Tian Z; Wu DY; Fu BY; Xin Y
World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
